FDA Panel Backs Atezolizumab for mTNBC -- at Least for Now ...Middle East

Medscape - News
FDA advisers voted 7-2 for keeping in place an approval for atezolizumab for a kind of metastatic triple-negative breast cancer while urging drugmaker Genentech to continue research on this indication. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Panel Backs Atezolizumab for mTNBC -- at Least for Now )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News